The neuromuscular junction (NMJ) is the principal site for the translation of motor neurochemical signals to muscle activity. Therefore, the release and sensing machinery of acetylcholine (ACh) along with muscle contraction are two of the principal targets of natural toxins and pathogens, causing paralysis.
Given pharmacology and medical advances, the active ingredients of toxins that target postsynaptic mechanisms have become of major interest, showing promise as drug leads. Herein, we review key facets of prevalent toxins modulating the mechanisms of ACh sensing and generation of the postsynaptic response, with muscle contraction.
We consider the correlation between their outstanding selectivity and potency and their effects on motor function, and discuss emerging data advocating their usage for the development of therapies alleviating neuromuscular dysfunction.